Eyedetec Medical

Eyedetec Medical

Early Stage

Chronic Dry Eye Therapy Reimagined

Chronic Dry Eye Therapy Reimagined

Overview

Raised to Date: Raised: $38,066

Total Commitments ($USD)

Platform

StartEngine

Start Date

02/22/2024

Close Date

04/28/2024

Min. Goal
$14,996
Max. Goal
$1,234,996
Min. Investment

$497

Security Type

Equity - Preferred

Series

Series A

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$3.88

Pre-Money Valuation

$15,198,193

Rolling Commitments ($USD)

Status

Active

Reporting Date

04/15/2024

Days Remaining

13

% of Min. Goal

254%

% of Max. Goal

3%

Likelihood of Max
unlikely
Avg. Daily Raise

$718

# of Investors

29

Momentum
cool.svg
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2010

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B2C

Margin

High

Capital Intensity

Low

Location

Danville, California

Business Type

Growth

Eyedetec Medical, with a valuation of $15.2 million, is raising funds on StartEngine. The company is developing a product for the treatment of chronic dry eye. Eyedetec Medical’s device, ELM, is a personalizthe ed device that can be used in office and at home to treat the root cause of dry eyes with warmth, vibrations, and neuro-modulation to deliver a soothing patient experience. Barry J Linder founded Eyedetec Medical in August 2010. The current crowdfunding campaign has a minimum target of $14,996.20 and a maximum target of $1.23 million. The campaign proceeds will be used for operations, research and development, and working capital.

Summary Profit and Loss Statement

FY 2023 FY 2022

Revenue

$411,720

$362,367

COGS

$120,112

$180,311

Tax

$0

$800

 

 

Net Income

$-635,392

$-884,110

Summary Balance Sheet

FY 2023 FY 2022

Cash

$301,838

$407,228

Accounts Receivable

$40,118

$17,385

Total Assets

$451,362

$521,914

Short-Term Debt

$1,041,720

$703,247

Long-Term Debt

$5,475,542

$5,249,175

Total Liabilities

$6,517,262

$5,952,422

Financials as of: 02/22/2024
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Eyedetec Medical on StartEngine 2024
Platform: StartEngine
Security Type: Equity - Preferred
Valuation: $15,198,193
Price per Share: $3.88

Follow company

Follow Eyedetec Medical on StartEngine 2024

Buy Eyedetec Medical's Deal Report

Eyedetec Medical Deal Report

Get KingsCrowd’s comprehensive report on Eyedetec Medical including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Eyedetec Medical is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Eyedetec Medical deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge